Printer Friendly

Generic AIDS drugs.

The U.S. Food and Drug Administration has tentatively approved generic versions of three AIDS drugs under the President's Emergency Plan for AIDS Relief, according to an FDA statement.

Two applications for generic versions of Viramune (nevirapine) and one each for generic versions of Retrovir (zidovudine) and Sustiva (efavirenz) were granted the tentative approval. This means that although existing patents and/or exclusivity prevent marketing in the United States, the products meet FDA quality, safety, and efficacy standards and are eligible for purchase and use outside the United States.

The President's Emergency Plan for AIDS Relief is providing $15 billion in the fight against HIV and AIDS, particularly in the hardest-hit countries. These tentative drug approvals aim to make safe, effective treatment available through the Plan as quickly as possible, according to the FDA.
COPYRIGHT 2005 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:CLINICAL CAPSULES; approval for AIDS drugs
Author:Worcester, Sharon
Publication:Internal Medicine News
Article Type:Brief Article
Date:Aug 15, 2005
Words:134
Previous Article:Syringe exchange programs.
Next Article:Lymphatic filariasis treatment.
Topics:


Related Articles
Lexiva[TM] (Fosamprenavir) approved.
AHF Applauds Gilead Sciences for Move to Increase Global Access to Affordable AIDS Drugs.
AIDS Healthcare Foundation Asks India's Trade Commission to Widen Cipla Drug Price Inquiry.
AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters